tirzepatide pancreatitis gallbladder disease warning label Safety issues of (pancreatitis and or biliary disease) in type It's important to study the

R., Thase, M

For many people using tirzepatide, a medication that supports weight loss, hitting a plateau can be frustrating

Weight loss of 10% or more may necessitate levothyroxine dose adjustments, and patients should be educated to recognise symptoms of both hypothyroidism (fatigue, cold intolerance, constipation) and hyperthyroidism (palpitations, anxiety, tremor) that might indicate the need for dose modification

Although the company discourages using the vial for multi-dosing (it doesnt contain a preservative), one option would be to inject 1 mg (0.05 mL) weekly for 2 weeks, 2 mg (0.1 mL) weekly for 2 weeks, then 4 mg (0.2 ml) weekly